Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care
Clinical trial NCT03371251 · COMPLETED
Trial details
- NCT number
- NCT03371251
- Sponsor
- Boston Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-10
- Primary completion
- 2020-11-26
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.